Cargando…

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis

Detalles Bibliográficos
Autores principales:	Koren, B, Blazina, Š, Toplak, N, Ključevšek, D, Avčin, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042274/ http://dx.doi.org/10.1186/1546-0096-11-S2-P304

Ejemplares similares

PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis
por: Semolič, N, et al.
Publicado: (2013)

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
por: Yamazaki, K, et al.
Publicado: (2013)

PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
por: Zajc Avramovič, M, et al.
Publicado: (2013)

Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course
por: Ključevšek, Damjana, et al.
Publicado: (2017)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

PReS-FINAL-2320: Different clinical presentation of takayasu arthritis: case report of two pediatric patients
por: Rukavina, I, et al.
Publicado: (2013)

The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
por: Toplak, Nataša, et al.
Publicado: (2018)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

PReS-FINAL-2209: MEFV gene mutations in central and south-eastern European countries
por: Perko, D, et al.
Publicado: (2013)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
por: Yurtsever, O, et al.
Publicado: (2013)

PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia
por: Dallos, T, et al.
Publicado: (2013)

PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis
por: Twilt, M, et al.
Publicado: (2013)

PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
por: Kienast, A, et al.
Publicado: (2013)

PReS-FINAL-2341: Perturbed homeostasis of FOXP3+ regulatory T cells and STAT1 signaling in SLE patients with childhood and adult onset of disease
por: Holcar, M, et al.
Publicado: (2013)

PReS-FINAL-2277: Clubbing fingers in a boy with arthritis
por: Giani, T, et al.
Publicado: (2013)

PReS-FINAL-2106: Clinical psoriatic arthritis of specific children
por: Chebisheva, S, et al.
Publicado: (2013)

PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus
por: Bean, AE, et al.
Publicado: (2013)

PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
por: Rossetto, E, et al.
Publicado: (2013)

The spectrum of clinical presentation in haploinsufficiency of A20; a case report of a novel mutation in TNFAIP3 gene
por: Debeljak, M., et al.
Publicado: (2023)

PReS13-SPK-1592: Pediatric aspects of antiphospholipid syndrome
por: Avcin, T
Publicado: (2013)

PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
por: Baydogan, SN, et al.
Publicado: (2013)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

PReS-FINAL-2024: Responsiveness of the juvenile arthritis foot disability index
por: Esbjörnsson, AC, et al.
Publicado: (2013)

PReS-FINAL-2334: Chronic recurrent multifocal osteomyelitis and tnf-αlfa inhibitors
por: Alberdi-Saugstrup, M, et al.
Publicado: (2013)

PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
por: Calzada-Hernández, J, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

PReS-FINAL-2256: Panniculitis revealing quantitative alpha 1 antitrypsine deficiency
por: Gagro, A, et al.
Publicado: (2013)

PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2013)

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013)

PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis
por: Noergaard, M, et al.
Publicado: (2013)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013)

PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
por: Kozhevnikov, A, et al.
Publicado: (2013)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis
por: Sørensen, SK
Publicado: (2013)

PReS-FINAL-2114: The leptin and adiponectin as biomarkers of atherosclerosis in juvenile rheumatic arthritis
por: Opoka-Winiarska, V, et al.
Publicado: (2013)

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hofneqmbrj2cs7btd0drjrevad